Our results demonstrated that MYO16-AS1 expression is significantly lower in LUAD tissue than in adjacent normal tissue and cancer cell lines than in normal cells and that low expression of MYO16-AS1 is associated with poor prognosis in LUAD patients. Here, MYO16 is linked to cancer.